المؤلفون: Hendrickx W., Simeone I., Anjum S., Mokrab Y., Bertucci F., Finetti P., Curigliano G., Seliger B., Cerulo L., Tomei S., Delogu L. G., Maccalli C., Wang E., Miller L. D., Marincola F. M., Ceccarelli M., Bedognetti D.

المساهمون: Hendrickx, W., Simeone, I., Anjum, S., Mokrab, Y., Bertucci, F., Finetti, P., Curigliano, G., Seliger, B., Cerulo, L., Tomei, S., Delogu, L. G., Maccalli, C., Wang, E., Miller, L. D., Marincola, F. M., Ceccarelli, M., Bedognetti, D.

مصطلحات موضوعية: Breast cancer, chemokine, exome sequencing, immune checkpoint, immune signature, immunologic constant of rejection, MAPK mutation, PD-L1, predictive signature, prognostic signature, triple negative

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28344865; info:eu-repo/semantics/altIdentifier/wos/WOS:000397987000015; volume:6; issue:2; firstpage:e1253654; journal:ONCOIMMUNOLOGY; http://hdl.handle.net/11577/3323567Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85011817556; http://www.tandfonline.com/loi/koni20Test

الإتاحة: https://doi.org/10.1080/2162402X.2016.1253654Test
http://hdl.handle.net/11577/3323567Test
http://www.tandfonline.com/loi/koni20Test

المؤلفون: Francesco M. Marincola, Wouter Hendrickx, Cristina Maccalli, Barbara Seliger, Pascal Finetti, Giuseppe Curigliano, Lance D. Miller, Ines Simeone, Younes Mokrab, François Bertucci, Michele Ceccarelli, Davide Bedognetti, Ena Wang, Luigi Cerulo, Samreen Anjum, Lucia Gemma Delogu, Sara Tomei

المساهمون: Multidisciplinary Breast Centre, UZ Leuven, Sidra Medical and Research Center, Department of Science and Technology, University of Sannio, Qatar Computing Research Institute [Doha, Qatar] (QCRI), Eli Lilly and Company Limited [Windlesham], Service d'Oncologie Médicale, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Division of Medical Oncology, European Institute of Oncology [Milan] (ESMO), Institute for Transfusion Medicine, University Hospital Essen, BIOGEM, University of Sassari, Department of Molecular Oncology, Foundation San Raffaele Scientific Institute, Wake Forest School of Medicine [Winston-Salem], Wake Forest Baptist Medical Center, Sidra Tower, Universitair Ziekenhuis Leuven (UZ Leuven), Università degli Studi di Sassari = University of Sassari [Sassari] (UNISS), Hendrickx, W., Simeone, I., Anjum, S., Mokrab, Y., Bertucci, F., Finetti, P., Curigliano, G., Seliger, B., Cerulo, L, Tomei, S., Delogu, L. G., Maccalli, C., Wang, E., Miller, L. D., Marincola, F. M., Ceccarelli, M., Bedognetti, D., MITOYAN, Louciné

المصدر: OncoImmunology
OncoImmunology, Taylor & Francis, 2017, 6 (2), ⟨10.1080/2162402X.2016.1253654⟩
OncoImmunology, 2017, 6 (2), ⟨10.1080/2162402X.2016.1253654⟩
OncoImmunology, Vol 6, Iss 2 (2017)
Oncoimmunology

مصطلحات موضوعية: 0301 basic medicine, lcsh:Immunologic diseases. Allergy, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Immunology, chemokines, chemical and pharmacologic phenomena, Biology, lcsh:RC254-282, triple negative, 03 medical and health sciences, 0302 clinical medicine, Immune system, Germline mutation, Breast cancer, breast cancer, pd-l1, medicine, Immunology and Allergy, Gene, immune checkpoint, Original Research, Genetics, immune signatures, prognostic signatures, predictive signatures, FOXP3, Immunotherapy, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Phenotype, Immune checkpoint, immunologic constant of rejection, 3. Good health, [SDV] Life Sciences [q-bio], 030104 developmental biology, Oncology, exome sequencing, MAPK mutations, PD-L1, 030220 oncology & carcinogenesis, lcsh:RC581-607, mapk mutations

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13cc6d52735d7b6387a46f04ae6286bfTest
http://hdl.handle.net/11567/996136Test